| Metric | Q3 2022 | Q2 2022 | Q3 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.0B | $586M | $781M | 71.8% | 29.0% |
| Op. Income | $125M | -$24M | -$36M | 611.4% | 447.2% |
| Gross Margin | 81.6% | 75.7% | 77.1% | 5.9pp | 4.4pp |
| Net Margin | 3.9% | 1.7% | -15.9% | 2.1pp | 19.7pp |
| EPS (Diluted) | $0.03 | $0.07 | $-0.19 | -55.1% | 116.7% |
| Free Cash Flow | $9M | $0 | $0 | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.0B |
| Cost of Revenue | $186M |
| GROSS PROFIT | $821M |
| R&D Expenses | $364M |
| Selling & Marketing | $209M |
| General & Administrative | $123M |
| SG&A Expenses | $333M |
| Other Expenses | $0 |
| Operating Expenses | $697M |
| Cost & Expenses | $882M |
| OPERATING INCOME | $125M |
| Interest Income | $66M |
| Interest Expense | $58M |
| Other Income/Expenses | -$49M |
| INCOME BEFORE TAX | $76M |
| Income Tax Expense | $40M |
| Net Income from Continuing Ops | $36M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $39M |
| D&A | $37M |
| EBIT | $125M |
| EBITDA | $162M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $1.0B |
| Cost of Revenue | $186M |
| GROSS PROFIT | $821M |
| R&D Expenses | $364M |
| Selling & Marketing | $209M |
| General & Administrative | $123M |
| SG&A Expenses | $333M |
| Other Expenses | $0 |
| Operating Expenses | $697M |
| Cost & Expenses | $882M |
| OPERATING INCOME | $125M |
| Interest Income | $66M |
| Interest Expense | $58M |
| Other Income/Expenses | -$49M |
| INCOME BEFORE TAX | $76M |
| Income Tax Expense | $40M |
| Net Income from Continuing Ops | $36M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $39M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $39M |
| D&A | $37M |
| EBIT | $125M |
| EBITDA | $162M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $39M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $51M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$81M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $9M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $9M |
| Net Change in Cash | -$111M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.8B |
| Short-Term Investments | $4.2B |
| Net Receivables | $899M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $9.8B |
| PP&E (Net) | $891M |
| Goodwill | $8.7B |
| Intangible Assets | $1.9B |
| Long-Term Investments | $6.9B |
| Tax Assets | $229M |
| Other Non-Current Assets | $59M |
| TOTAL NON-CURRENT ASSETS | $18.6B |
| TOTAL ASSETS | $28.4B |
| Account Payables | $1.1B |
| Short-Term Debt | $4.9B |
| Deferred Revenue | $1.1B |
| Other Current Liabilities | $1.8B |
| TOTAL CURRENT LIABILITIES | $9.0B |
| Long-Term Debt | $2.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $508M |
| Other Non-Current Liabilities | $27M |
| TOTAL NON-CURRENT LIABILITIES | $3.2B |
| TOTAL LIABILITIES | $12.2B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $16.1B |
| TOTAL STOCKHOLDERS' EQUITY | $16.1B |
| Minority Interest | $104M |
| TOTAL EQUITY | $16.2B |
| TOTAL LIABILITIES & EQUITY | $28.4B |
| Total Debt | $7.6B |
| Net Debt | $4.8B |
